Stem cells as a potential therapy for necrotizing enterocolitis

Expert Opinion on Biological Therapy

Volumn 13, Issue 12, 2013, Pages 1683-1689

  Eaton, Simon ^a   Zani, Augusto ^a   Pierro, Agostino ^b   De Coppi, Paolo ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Amniotic fluid; Amniotic fluid stem cells; Cyclooxygenase 2; Intestinal epithelial cells; Necrotizing enterocolitis

Indexed keywords

ANTIBIOTIC AGENT; CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR 2; INOTROPIC AGENT; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

AMNIOTIC FLUID CELL; AMNIOTIC FLUID STEM CELL; APOPTOSIS; ARTIFICIAL VENTILATION; CELL MIGRATION; CELL PROLIFERATION; HEMATOPOIETIC STEM CELL; HUMAN; INTESTINE EPITHELIUM CELL; MESENCHYMAL STEM CELL; NECROTIZING ENTEROCOLITIS; NONHUMAN; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PREMATURITY; REGENERATIVE MEDICINE; REVIEW; RODENT MODEL; STEM CELL TRANSPLANTATION; SURVIVAL TIME; TREATMENT OUTCOME;

ANIMALS; CELL- AND TISSUE-BASED THERAPY; ENTEROCOLITIS, NECROTIZING; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84887872833     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.849690     Document Type: Review

References (62)

1. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med 2011;364:255-64
2. Rees CM, Eaton S, Pierro A. Trends in infant mortality from necrotising enterocolitis in England and Wales and the USA. Arch Dis Child Fetal Neonatal Ed 2008;93:F395-6
3. Hackam DJ, Good M, Sodhi CP. Mechanisms of gut barrier failure in the pathogenesis of necrotizing enterocolitis: Toll-like receptors throw the switch. Semin Pediatr Surg 2013;22:76-82
4. Sampath V, Le M, Lane L, et al. The NFKB1 (g-24519delATTG) variant is associated with necrotizing enterocolitis (NEC) in premature infants. J Surg Res 2011;169:E51-7
5. Treszl A, Tulassay T, Vasarhelyi B. Genetic basis for necrotizing enterocolitis -Risk factors and their relations to genetic polymorphisms. Front Biosci 2006;11:570-80
6. Kelleher J, Mallick H, Soltau TD, et al. Mortality and intestinal failure in surgical necrotizing enterocolitis. J Pediatr Surg 2013;48:568-72
7. Rees CM, Pierro A, Eaton S. Neurodevelopmental outcomes of neonates with medically and surgically treated necrotizing enterocolitis. Arch Dis Child Fetal Neonatal Ed 2007;92:F193-8
8. Eaton S, Hall NJ. The potential of probiotics in the fight against necrotizing enterocolitis. Expert Rev Gastroenterol Hepatol 2013;In press
9. Caplan M, Frost B. Myth: Necrotizing enterocolitis: Probiotics will end the disease, and surgical intervention improves the outcome. Semin Fetal Neonatal Med 2011;16:264-8
10. Elliott MJ, De CP, Speggiorin S, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: A 2-year follow-up study. Lancet 2012;380:994-1000
11. Cassinotti A, Annaloro C, Ardizzone S, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease. Gut 2008;57:211-7
12. Clevers H, Batlle E. SnapShot: The intestinal crypt. Cell 2013;152:1198
13. Hall PA, Coates PJ, Ansari B, Hopwood D. Regulation of cell number in the mammalian gastrointestinal-tract -the importance of apoptosis. J Cell Sci 1994;107:3569-77
14. Ballance WA, Dahms BB, Shenker N, Kliegman RM. Pathology of neonatal necrotizing enterocolitis: A ten-year experience. J Pediatr 1990;117:S6-13
15. Sebire NJ, Thyoka M, Pierro A, Eaton S. Histological and immunohistochemical features associated with outcome in neonatal necrotizing enterocolitis. Eur J Pediatr Surg 2013;In press
16. Evennett NJ, Hall NJ, Pierro A, Eaton S. Urinary intestinal fatty acid-binding protein concentration predicts extent of disease in necrotizing enterocolitis. J Pediatr Surg 2010;45:735-40
17. Jilling T, Lu J, Jackson M, Caplan MS. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004;55:622-9
18. Zani A, Cananzi M, Fascetti-Leon F, et al. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut 2013; [Epub ahead of print].
19. Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997;32:275-82
20. Neal MD, Sodhi CP, Dyer M, et al. A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis. J Immunol 2013;190:3541-51
21. Maynard AA, Dvorak K, Khailova L, et al. Epidermal growth factor reduces autophagy in intestinal epithelium and in the rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2010;299:G614-22
22. Joshi VV, Winston YE, Kay S. Neonatal necrotizing enterocolitis -histologic evidence of healing. Am J Dis Child 1973;126:113-6
23. Schaart MW, de Bruijn AC, Bouwman DM, et al. Epithelial functions of the residual bowel after surgery for necrotising enterocolitis in human infants. J Pediatr Gastroenterol Nutr 2009;49:31-41
24. Vieten D, Corfield A, Carroll D, et al. Impaired mucosal regeneration in neonatal necrotising enterocolitis. Pediatr Surg Int 2005;21:153-60
25. Vieten D, Corfield A, Ramani P, Spicer R. Proliferative response in necrotising enterocolitis is insufficient to prevent disease progression. Pediatr Surg Int 2006;22:50-6
26. Feng J, Besner GE. Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg 2007;42:214-20
27. Le Mandat Schultz A, Bonnard A, Berrebi D, Peuchmaur M. Expression of TLR-2, TLR-4, NOD2 and pNF-ÎoB in a neonatal rat model of necrotizing enterocolitis. PLoS One 2007;2:e1102
28. Gosden CM. Amniotic fluid cell types and culture. Br Med Bull 1983;39:348-54
29. Hoehn H, Salk D. Morphological and biochemical heterogeneity of amniotic fluid cells in culture. Methods Cell Biol 1982;26:11-34
30. Hoehn H, Bryant EM, Karp LE, Martin GM. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. II. Cytogenetic parameters as functions of clonal type and preparative technique. Clin Genet 1975;7:29-36
31. Gosden C, Brock DJ. Combined use of alphafetoprotein and amniotic fluid cell morphology in early prenatal diagnosis of fetal abnormalities. J Med Genet 1978;15:262-70
32. Siegel N, Rosner M, Hanneder M, et al. Stem cells in amniotic fluid as new tools to study human genetic diseases. Stem Cell Rev 2007;3:256-64
33. Kaviani A, Perry TE, Dzakovic A, et al. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 2001;36:1662-5
34. Anker PS, Scherjon SA, Kleijburg-Van Der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 2003;102:1548-9
35. Prusa AR, Marton E, Rosner M, et al. Oct-4-expressing cells in human amniotic fluid: A new source for stem cell research? Hum Reprod 2003;18:1489-93
36. De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-6
37. Ditadi A, De CP, Picone O, et al. Human and murine amniotic fluid c-Kit +Lin-cells display hematopoietic activity. Blood 2009;113:3953-60
38. Moschidou D, Mukherjee S, Blundell MP, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther 2012;20:1953-67
39. Piccoli M, Franzin C, Bertin E, et al. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn (F7/F7) mouse model. Stem Cells 2012;30:1675-84
40. Pederiva F, Ghionzoli M, Pierro A, et al. Amniotic fluid stem cells rescue both in vitro and in vivo growth, innervation, and motility in nitrofen-exposed hypoplastic rat lungs through paracrine effects. Cell Transplant 2013;22(9):1683-94
41. Bollini S, Cheung KK, Riegler J, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev 2011;20:1985-94
42. Gosemann JH, Kuebler JF, Pozzobon M, et al. Activation of regulatory T cells during inflammatory response is not an exclusive property of stem cells. PLoS One 2012;7:e35512
43. Okamoto R, Yajima T, Yamazaki M, et al. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med 2002;8:1011-7
44. Bamba S, Lee CY, Brittan M, et al. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol 2006;209:265-73
45. Tanaka F, Tominaga K, Ochi M, et al. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci 2008;83:771-9
46. Zani A, Cananzi M, Lauriti G, et al. Amniotic fluid stem cells prevent development of ascites in a neonatal rat model of necrotizing enterocolitis. Eur J Pediatr Surg 2013;In press
47. Ghionzoli M, Cananzi M, Zani A, et al. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: Implication for therapy. Pediatr Surg Int 2010;26:79-84
48. Tessner TG, Muhale F, Riehl TE, et al. Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation. J Clin Invest 2004;114:1676-85
49. Gilroy DW, Colville-Nash PR, Willis D, et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999;5:698-701
50. Brown SL, Riehl TE, Walker MR, et al. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest 2007;117:258-69
51. McElroy SJ, Hobbs S, Kallen M, et al. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One 2012;7(5):e38373
52. Sobolewski C, Cerella C, Dicato M, et al. The role of cyclooxygenase-2 in cell proliferation and cell death in human malignancies. Int J Cell Biol 2010;2010:215158
53. Tayman C, Uckan D, Kilic E, et al. Mesenchymal stem cell therapy in necrotizing enterocolitis: A rat study. Pediatr Res 2011;70:489-94
54. Yang JX, Watkins D, Chen CL, et al. Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg 2012;215:534-45
55. Siggers J, Ostergaard MV, Siggers RH, et al. Postnatal amniotic fluid intake reduces gut inflammatory responses and necrotizing enterocolitis in preterm neonates. Am J Physiol Gastrointest Liver Physiol 2013;304:G864-75
56. Good M, Siggers RH, Sodhi CP, et al. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci USA 2012;109:11330-5
57. Derikx JP, Evennett NJ, Degraeuwe PL, et al. Urine based detection of intestinal mucosal cell damage in neonates with suspected necrotising enterocolitis. Gut 2007;56:1473-5
58. Mannoia K, Boskovic DS, Slater L, et al. Necrotizing enterocolitis is associated with neonatal intestinal injury. J Pediatr Surg 2011;46:81-5
59. Totonelli G, Maghsoudlou P, Garriboli M, et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials 2012;33:3401-10
60. Grant CN, Grikscheit TC. Tissue engineering: A promising therapeutic approach to necrotizing enterocolitis. Semin Pediatr Surg 2013;22:112-16
61. Sonntag J,Wagner MH, Waldschmidt J, et al.Multisystem organ failure and capillary leak syndrome in severe necrotizing enterocolitis of very low birth weight infants. J Pediatr Surg 1998;33:481-4
62. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007;449:1003-7